Assertio therapeutics announces sale of gralise for total value of $127.5 million

Assertio therapeutics announces sale of gralise® for total transaction value of $127.5 million.assertio therapeutics inc - alvogen will pay assertio a total value of $127.5 million.assertio therapeutics inc - both cos expect majority of royalties to be paid in first calendar year.assertio therapeutics inc - deal value of $127.5 million includes $75 million in cash and balance payable in form of a royalty.assertio therapeutics - entered into agreement with alvogen under which alvogen will acquire & assume all responsibilities related to product gralise.
ASRT Ratings Summary
ASRT Quant Ranking